Moreno-Ruiz LA, Mendoza-Pérez BC, Santillano-Gómez E, Jiménez-Arteaga S, Borrayo-Sánchez G, Alva-Espinosa C

Language: Spanish
References: 13
Page: 435-438
PDF size: 295.73 Kb.

ABSTRACT

Background: Antiphospholipid antibody syndrome (APS) is characterized by the association among arterial or venous thrombosis, recurrent pregnancy loss, thrombocytopenia and the presence of circulating antiphospholipid antibodies. Antiphospholipid antibody-related thrombosis seems to constitute a significant proportion of childhood thrombosis. We present the case of an adolescent female with non-ST-elevation acute myocardial infarction secondary to APS.
Clinic case: We present the case of a 14-year old female with a history of idiopathic thrombocytopenic purpura whose symptomatology initiated with oppressive chest pain, dyspnea, diaphoresis and wamble. During the physical exam she had tachycardia, accentuation of the second heart sound, a mesosystolic murmur in the pulmonary focus and pulmonary rales. Electrocardiogram showed ST-segment depression in anterior and lateral wall and positive enzymatic curve for infarction. Clinical study reported anterolateral and apical infarction, ostium secundum atrial septal defect and APS.
Conclusions: Many studies have demonstrated the diversity of clinical features associated with APS in children and teenagers including deep venous thrombosis, stroke, digital ischemia, pulmonary vasoocclusive disease and, more rarely, acute myocardial infarction. In pediatric patients with acute myocardial infarction we must consider the possibility of APS even though coronary thrombotic occlusion is one of the rarest manifestations.

REFERENCES

1. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999;353:1348-1353.

2. Gezer S. Antiphospholipid syndrome. Dis Mon 2003;49:691-742

3. Von Scheven EV, Athreya BH, Rose CD, Goldsmith DP, Morton L. Clinical characteristics of antiphospholipid antibody syndrome in children. J Pediatr 1996;129:339-345.

4. Avcin T, Silverman E. Review: Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus 2007;16:627-633.

5. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J, et al. The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine 1989;68:366-374.

6. Alarcón-Segovia D, Pérez-Vásquez ME, Vila AR, Villa AR, Drenkard C, Cabiedes J. Preliminary classification criteria for antiphospholipid syndrome within systemic lupus erytematosus. Semin Arthritis Rheum 1992;21:275-286.

7. Ravelli A, Martini A. Antiphospholipid antibody syndrome in pediatric patients. Rheum Dis Clin North Am 1997;23:657-676.

8. Avcin T, Cimaz R, Silverman ED, Cervera R, Gattorno M, Garay S, et al. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics 2008;122:e1100-e1107.

9. Mahle WT, Campbell RM, Favaloro-Sabatier J. Myocardial infarction in adolescents. J Pediatr 2007;151:150-154.

10. Angelini PA, Velasco JA, Flamm S. Coronary anomalies. Incidence, pathophysiology and clinical relevance. Circulation 2002;105:2449-2454.

11. Bagby GC, Goldman RD, Newman HC, Means JF. Acute myocardial infarction due to childhood lymphoma. N Engl J Med 1972;287:338-340.

12. Lane JR, Ben Shachar G. Myocardial infarction in healthy adolescents. Pediatrics 2007;120:938-943.

13. Monagle P. Thrombosis in pediatric cardiac patients. Semin Thromb Hemost 2003;29:547-555.